First US sale for USCOM
Thursday, 28 July, 2005
Sydney-based devices company USCOM (ASX:UCM) has received its first US orders for its heart monitoring equipment. The USCOM Ultrasonic Cardiac Output Monitor, which the company says uses ultrasound technology to cost-effectively and non-invasively measure blood flow across the cardiac valves, was purchased by the Regional Healthcare System for Florida.
USCOM has also advanced the monitor's technology and the latest version of USCOM operating system software includes real-time calculation of beat-to-beat Systemic Vascular Resistance (SVR), a cardiovascular measure relating to cardiac output and blood pressure.
USCOM secured FDA approval to market the device in US in February and has had first sales in 11 other countries, including Australia.
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
